Alkaloids from frog skin: the discovery of epibatidine and the potential for developing novel non-opioid analgesics
Abstract
The first page of this article is displayed as the abstract.
a Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892
b Neurological and Urological Diseases Research, Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, IL 60064-6125
The first page of this article is displayed as the abstract.
Alkaloids from frog skin: the discovery of epibatidine and the potential for developing novel non-opioid analgesics
J. W. Daly, H. Martin Garraffo, T. F. Spande, M. W. Decker, J. P. Sullivan and M. Williams, Nat. Prod. Rep., 2000, 17, 131 DOI: 10.1039/A900728H
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content